China NMPA Product Recall - Fully automated sample processing system

Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. reported a voluntary recall concerning the Fully Automated Sample Processing System, manufactured by Ortho-Clinical Diagnostics, Inc., on May 25, 2015. The recall was initiated due to identified issues with the capping machine module and its associated cap, which could cause sample tube caps to dislodge. Additionally, the clamping device might fail to properly secure sample tubes, leading them to fall within the system. These malfunctions pose a risk of splashing biohazardous liquids and potential cross-contamination if uncapped samples are present. Operating under the National Medical Products Administration (NMPA) framework, Johnson & Johnson (Shanghai) disclosed that the specific affected product models and components were not imported into or sold within China. Consequently, the Chinese market remains unaffected by these issues. As a result, the company's required action in China was limited to formally reporting the voluntary recall to the NMPA. No further recall activities, investigations, or implementation plans were necessitated for the Chinese market, as the identified risks did not apply locally. This report served to inform the regulatory body of an international product safety concern without requiring domestic corrective measures.